Altogether, these findings identify Epac1 as a central mechanism for mitochondrial Ca2+ entry and ROS production in myocardial cell death, and indicate that mitochondrial-targeted Epac1 inhibition could prevent or reduce myocardial death in the setting of cardiac ischemia. Here, RAPGEF3 is linked to myocardial ischemia.